TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3.Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2.Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of LivaNova PLC
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, BY PRODUCT
6.1. Overview
6.2. Implantable Cardioverter Defibrillators
6.2.1. Transvenous implantable Cardioverter Defibrillators
6.2.1.1. Biventricular Implantable Cardioverter Defibrillators/Cardiac Resynchronization Therapy Defibrillators
6.2.1.2. Dual-Chamber Implantable Cardioverter Defibrillators
6.2.1.3. Single-Chamber Implantable Cardioverter Defibrillators
6.2.2. Subcutaneous implantable Cardioverter Defibrillators
6.3. Ventricular Assist Devices
6.4. Implantable Heart Monitors/Insertable Loop Recorders
6.5. Neurostimulators
6.5.1. Spinal Cord Stimulators
6.5.2. Deep Brain Stimulators
6.5.3. Sacral Nerve Stimulators
6.5.4. Vagus Nerve Stimulators
6.5.5. Gastric Electrical Stimulators
6.6. Implantable Hearing Devices
6.6.1. Active Hearing Implant
6.6.2. Non-Active/Passive Hearing Implants
7. GLOBAL ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, BY REGION
7.1. Overview
7.2. North America
7.2.1. US
7.2.2. Canada
7.3. Europe
7.3.1. Germany
7.3.2. France
7.3.3. UK
7.3.4. Italy
7.3.5. Spain
7.3.6. Rest of Europe
7.4. Asia-Pacific
7.4.1. China
7.4.2. India
7.4.3. Japan
7.4.4. South Korea
7.4.5. Australia
7.4.6. Rest of Asia-Pacific
7.5. Rest of the World
7.5.1. Middle East
7.5.2. Africa
7.5.3. Latin America
8. COMPETITIVE LANDSCAPE
8.1. Overview
8.2. Competitive Analysis
8.3. Market Share Analysis
8.4. Major Growth Strategy in the Global Antimicrobial Coatings for Medical Devices Market,
8.5. Competitive Benchmarking
8.6. Leading Players in Terms of Number of Developments in the Global Antimicrobial Coatings for Medical Devices Market,
8.7. Key developments and Growth Strategies
8.7.1. New Product Launch/Service Deployment
8.7.2. Merger & Acquisitions
8.7.3. Joint Ventures
8.8. Major Players Financial Matrix
8.8.1. Sales & Operating Income, 2023
8.8.2. Major Players R&D Expenditure. 2023
9. COMPANY PROFILES
9.1. MEDTRONIC PLC
9.1.1. Company Overview
9.1.2. Financial Overview
9.1.3. Products Offered
9.1.4. Key Developments
9.1.5. SWOT Analysis
9.1.6. Key Strategies
9.2. Abbott Laboratories
9.2.1. Company Overview
9.2.2. Financial Overview
9.2.3. Products Offered
9.2.4. Key Developments
9.2.5. SWOT Analysis
9.2.6. Key Strategies
9.3. Boston Scientific Corporation
9.3.1. Company Overview
9.3.2. Financial Overview
9.3.3. Products Offered
9.3.4. Key Developments
9.3.5. SWOT Analysis
9.3.6. Key Strategies
9.4. Biotronik SE & Co. KG
9.4.1. Company Overview
9.4.2. Financial Overview
9.4.3. Products Offered
9.4.4. Key Developments
9.4.5. SWOT Analysis
9.4.6. Key Strategies
9.5. Cochlear Limited
9.5.1. Company Overview
9.5.2. Financial Overview
9.5.3. Products Offered
9.5.4. Key Developments
9.5.5. SWOT Analysis
9.5.6. Key Strategies
9.6. Zimmer Biomet Holdings, Inc.
9.6.1. Company Overview
9.6.2. Financial Overview
9.6.3. Products Offered
9.6.4. Key Developments
9.6.5. SWOT Analysis
9.6.6. Key Strategies
9.7. LivaNova PLC
9.7.1. Company Overview
9.7.2. Financial Overview
9.7.3. Products Offered
9.7.4. Key Developments
9.7.5. SWOT Analysis
9.7.6. Key Strategies
9.8. Edwards Lifesciences Corporation
9.8.1. Company Overview
9.8.2. Financial Overview
9.8.3. Products Offered
9.8.4. Key Developments
9.8.5. SWOT Analysis
9.8.6. Key Strategies
9.9. TERUMO CORPORATION
9.9.1. Company Overview
9.9.2. Financial Overview
9.9.3. Products Offered
9.9.4. Key Developments
9.9.5. SWOT Analysis
9.9.6. Key Strategies
9.10. SONOVA HOLDING AG
9.10.1. Company Overview
9.10.2. Financial Overview
9.10.3. Products Offered
9.10.4. Key Developments
9.10.5. SWOT Analysis
9.10.6. Key Strategies
10. APPENDIX
10.1. References
10.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 4 NORTH AMERICA: ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 5 US: ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 6 CANADA: ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 1 EUROPE: ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 2 GERMANY: ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 3 FRANCE: ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 4 ITALY: ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 5 SPAIN: ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 6 UK: ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 7 REST OF EUROPE: ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 8 ASIA-PACIFIC: ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 9 JAPAN: ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 10 CHINA: ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 11 INDIA: ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 12 AUSTRALIA: ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 13 SOUTH KOREA: ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 14 REST OF ASIA-PACIFIC: ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 15 REST OF THE WORLD: ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 16 MIDDLE EAST: ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, BY PRODUCT, 2019-
TABLE 17 AFRICA: ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 18 LATIN AMERICA: ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET
FIGURE 4 GLOBAL ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, SHARE (%), BY PRODUCT, 2023
FIGURE 5 GLOBAL ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, SHARE (%), BY DEVICE TYPE, 2023
FIGURE 6 GLOBAL ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, SHARE (%), BY REGION, 2023
FIGURE 7 NORTH AMERICA: ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, SHARE (%), BY REGION, 2023
FIGURE 8 EUROPE: ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 ASIA-PACIFIC: ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 REST OF THE WORLD: ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 GLOBAL ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 12 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 13 MEDTRONIC PLC: SWOT ANALYSIS
FIGURE 14 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 ABBOTT LABORATORIES: SWOT ANALYSIS
FIGURE 16 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS
FIGURE 18 BIOTRONIK SE & CO. KG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 BIOTRONIK SE & CO. KG: SWOT ANALYSIS
FIGURE 20 COCHLEAR LIMITED: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 COCHLEAR LIMITED: SWOT ANALYSIS
FIGURE 22 ZIMMER BIOMET HOLDINGS, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 ZIMMER BIOMET HOLDINGS, INC.: SWOT ANALYSIS
FIGURE 24 LIVANOVA PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 LIVANOVA PLC: SWOT ANALYSIS
FIGURE 26 EDWARDS LIFESCIENCES CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 EDWARDS LIFESCIENCES CORPORATION: SWOT ANALYSIS
FIGURE 28 TERUMO CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 TERUMO CORPORATION: SWOT ANALYSIS
FIGURE 30 SONOVA HOLDING AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 SONOVA HOLDING AG: SWOT ANALYSIS
